Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: A bedside test for diagnosing long QT syndrome

European Heart Journal

Volumn 27, Issue 4, 2006, Pages 469-475

  Viskin, Sami ^a   Rosso, Raphael ^a   Rogowski, Ori ^a   Belhassen, Bernard ^a   Levitas, Aviva ^b   Wagshal, Abraham ^b   Katz, Amos ^b   Fourey, Dana ^a   Zeltser, David ^a   Oliva, Antonio ^c   Pollevick, Guido D ^c   Antzelevitch, Charles ^c   Rozovski, Uri ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

Adenosine; Electrocardiogram; Long QT syndrome; Torsade de pointes

Indexed keywords

ADENOSINE;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; LONG QT SYNDROME; MALE; MORPHOLOGY; POINT OF CARE TESTING; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SINUS RHYTHM; SINUS TACHYCARDIA; T WAVE; TACHYCARDIA;

ADENOSINE; ADULT; ANTI-ARRHYTHMIA AGENTS; BRADYCARDIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; LONG QT SYNDROME; MALE; POINT-OF-CARE SYSTEMS; TACHYCARDIA;

EID: 32144452025     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi460     Document Type: Article

References (32)

1. Viskin S. The long QT syndromes and torsade de pointes. Lancet 1999;354:1625-1633.
2. Moss AJ. Long QT syndrome. JAMA 2003;289:2041-2044.
3. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. N Engl J Med 1992;327:846-852.
4. Allan WC, Timothy K, Vincent GM, Palomaki GE, Neveux LM, Haddow JE. Long QT syndrome in children: the value of rate corrected QT interval and DNA analysis as screening tests in the general population. J Med Screen 2001;8:173-177.
5. Vincent GM. Role of DNA testing for diagnosis, management and genetic screening in long QT syndrome, hypertrophic cardiomyopathy and Marfan syndrome. J Cardiovasc Electrophysiol 2001;86:12-14.
6. Merri M, Moss AJ, Benhorin J, Locati EH, Alberti M, Badilini F. Relation between ventricular repolarization duration and cardiac cycle length during 24-hour Holter recordings. Findings in normal patients and patients with long QT syndrome. Circulation 1992;85:1816-1821.
7. Cruz Filho FE, Maia IG, Fagundes ML, Barbosa RC, Alves PA, Sa RM, Boghossian SH, Ribeiro JC. Electrical behavior of T-wave polarity alternans in patients with congenital long QT syndrome. J Am Coll Cardiol 2000;36:167-173.
8. Chinushi M, Restivo M, Caref EB, El-Sherif N. Electrophysiological basis of arrhythmogenicity of QT/T alternans in the long QT syndrome: tridimensional analysis of the kinetics of cardiac repolarization. Circ Res 1998;83:614-628.
9. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988;31:115-172.
10. Viskin S, Zelster D, Antzelevitch C. When u say 'U Waves', what do u mean? Pacing Clin Electrophysiol 2004;27:145-147.
11. Viskin S, Alla SR, Barron HV, Heller K, Saxon L, Kitzis I, Van Hare GF, Wong MJ, Lesh MD, Scheinman MM. Mode of onset of torsade de pointes in congenital long QT syndrome. J Am Coll Cardiol 1996;28:1262-1268.
12. Viskin S, Fish R, Zeltser D, Heller K, Brosh D, Laniado S, Barron HV. Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause-dependent? Heart 2000;83:661-666.
13. Belhassen B, Viskin S. What is the drug of choice for the acute termination of paroxysmal supraventricular tachycardia: verapamil, adenosine triphosphate, or adenosine? Pacing Clin Electrophysiol 1993;16:1735-1741.
14. Belhassen B, Fish R, Glikson M, Glick A, Eldar M, Laniado S, Viskin S. Noninvasive diagnosis of dual AV node physiology in patients with AV nodal reentrant tachycardia by administration of adenosine-5′-triphosphate during sinus rhythm. Circulation 1998;98:47-53.
15. Viskin S, Fish R, Glick A, Glikson M, Eldar M, Belhassen B. The adenosine triphosphate test: a bedside diagnostic tool for identifying the mechanism of supraventricular tachycardia in patients with palpitations. J Am Coll Cardiol 2001;38:173-177.
16. Lerman BB, Belardinelli L. Cardiac electrophysiology of adenosine: basic and clinical concepts. Circualtion 1991;83:1499-1509.
17. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993;88:782-784.
18. Vincent GM. How to make the diagnosis of Long QT syndrome in patients with reduced penetrance of the prolonged QT phenotype when DNA testing is not available or is negative. First International Symposium on Long QT Syndrome. http://www.lqts-symposium.org/topics/ing_vincent.pdf (2004).
19. Takenaka K, Ai T, Shimizu W, Kobori A, Ninomiya T, Otani H, Kubota T, Takaki H, Kamakura S, Horie M. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 2003;107:838-844.
20. Dillenburg RF, Hamilton RM. Is exercise testing useful in identifying congenital long QT syndrome? Am J Cardiol 2002;89:233-236.
21. Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K, Suyama K, Aihara N, Kamakura S, Sunagawa K, Echigo S, Nakamura K, Ohe T, Towbin JA, Napolitano C, Priori SG. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol 2003;41:633-642.
22. Ackerman MJ, Khositseth A, Tester DJ, Hejlik JB, Shen WK, Porter CB. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc 2002;77:413-421.
23. Viskin S. Drug challenge with epinephrine or isoproterenol for diagnosing a long QT syndrome: Should we try this at home? J Cardiovasc Electrophysiol 2005;16:285-287.
24. Belardinelli L, Isenberg G. Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res 1983;53:287-297.
25. Khositseth A, Hejlik JB, Shen WK, Ackerman MJ. Epinephrine-induced T-wave notching in congenital long QT syndrome. Heart Rhythm 2005;2:141-146.
26. Biaggioni I, Killian TJ, Mosqueda-Garcia R, Robertson RM, Robertson D. Adenosine increases sympathetic nerve traffic in humans. Circulation 1991;83:1668-1675.
27. Shimizu W, Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long QT syndrome. Effects of beta-adrenergic agonists and antagonists and sodium channels blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 1998;98:2314-2322.
28. Nemec J, Buncova M, Bulkova V, Hejlik J, Winter B, Shen WK, Ackerman MJ. Heart rate dependence of the QT interval duration: differences among congenital long QT syndrome subtypes. J Cardiovasc Electrophysiol 2004;15:550-556.
29. Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, Suyama K, Aihara N, Sunagawa K, Echigo S, Miyamoto Y, Yoshimasa Y, Nakamura K, Ohe T, Towbin JA, Priori SG, Kamakura S. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congential long QT syndrome. Heart Rhythm 2004;3:273-286.
30. Wesley RC, Turnquest P. Torsade de pointes after intravenous adenosine in the presence of prolonged QT syndrome. Am Heart J 1992;123:794-796.
31. Harrington GR, Froelich EG. Adenosine-indued torsade de pointes. Chest 1993;103:1299-1301.
32. Viskin S, Fish R, Roth A, Copperman Y. Prevention of torsade de pointes in the congenital long QT syndrome: use of a pause-prevention pacing algorithm. Heart 1998;79:417-419.